FAM
HQL

Formidable Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Formidable Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
165,243
+6,858
+4% +$121K 0.43% 47
2026
Q1 		$2.66M Buy
158,385
+33,940
+27% +$567K 0.41% 45
2025
Q4 		$1.93M Buy
124,445
+48,252
+63% +$811K 0.28% 66
2025
Q3 		$976K Buy
76,193
+12,214
+19% +$167K 0.15% 132
2025
Q2 		$812K Hold
63,979
– – 0.14% 140
2025
Q1 		$812K Buy
+63,979
New +$866K 0.14% 143

Other funds holding HQL

FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
CEFA
Closed-End Fund Advisors Richmond, Virginia $102M AUM
KAS
KPP Advisory Services Louisville, Kentucky $791M AUM 28.5% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
PFO
PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return

Formidable Asset Management's HQL Position: Q2 2026 in Review

Formidable Asset Management increased its abrdn Life Sciences Investors (HQL) stake by 4.3% in Q2 2026, buying an estimated $121K and bringing the position to 165,243 shares worth $2.69M. The position accounts for 0.43% of the portfolio, ranked #47.

Formidable Asset Management first reported a position in HQL in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Formidable Asset Management held 165,243 shares of abrdn Life Sciences Investors worth $2.69M as of Q2 2026.
  • Formidable Asset Management bought 6,858 abrdn Life Sciences Investors shares in Q2 2026, an estimated $121K.
  • abrdn Life Sciences Investors made up 0.43% of Formidable Asset Management's portfolio in Q2 2026, its #47 holding.
  • Formidable Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2025 and has held it in 6 quarters since.
  • 35 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.